Literature DB >> 36044479

Retraction: MicroRNA-424 Is Down-Regulated in Hepatocellular Carcinoma and Suppresses Cell Migration and Invasion through c-Myb.

.   

Abstract

Entities:  

Year:  2022        PMID: 36044479      PMCID: PMC9432760          DOI: 10.1371/journal.pone.0274145

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


× No keyword cloud information.
Following the publication of this article [1], similarities were noted between this article and articles submitted by other research groups, including [2-6], of which several were previously retracted [7-9]. Similarities included the following figures, which appear to fully or partially overlap, despite being published in different articles and representing different conditions: The inhibitor panel in Fig 3B of [1], the inhibitor panel in Fig 2D of [2] and the miR-145 mimics PANC-1 panel in Fig 4C of [3]. The 0h scramble panel in Fig 3A of [1], and the 0h control panel in Fig 4F of [4]. The 24h scramble panel in Fig 3A of [1], and the 48h control panel in Fig 4F of [4]. The pcDNA-c-Myb + miR-424 panel in Fig 5D of [1], and the control-2 panel in Fig 2E of [5]. The pcDNA + scramble panel in Fig 5D of [1] flipped horizontally and vertically, and the inhibitor panel in Fig 2E of [5]. The corresponding author stated that their article [1] may be similar to others [2-6] because they believe their data may have been used by others without their knowledge or permission as it was not stored securely. They provided data files which do not resolve the concerns regarding similarities between the published articles [1-6]. The unresolved concerns call into question the validity and provenance of the reported results, and the adherence of this article to the PLOS Authorship policy. Therefore, the PLOS ONE Editors retract this article [1]. LZ did not agree with the retraction. All other authors either did not respond directly or could not be reached.
  9 in total

1.  MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma.

Authors:  Lei Yu; Luting Zhou; Yu Cheng; Lei Sun; Jian Fan; Jinlong Liang; Mujie Guo; Ning Liu; Liying Zhu
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

2.  Retraction: MicroRNA-410 Suppresses Migration and Invasion by Targeting MDM2 in Gastric Cancer.

Authors: 
Journal:  PLoS One       Date:  2022-06-08       Impact factor: 3.752

3.  Retraction: MicroRNA-503 Acts as a Tumor Suppressor in Osteosarcoma by Targeting L1CAM.

Authors: 
Journal:  PLoS One       Date:  2022-06-08       Impact factor: 3.752

4.  Retraction: MicroRNA-217 Regulates WASF3 Expression and Suppresses Tumor Growth and Metastasis in Osteosarcoma.

Authors: 
Journal:  PLoS One       Date:  2022-06-08       Impact factor: 3.752

5.  MicroRNA-424 is down-regulated in hepatocellular carcinoma and suppresses cell migration and invasion through c-Myb.

Authors:  Lei Yu; Guo-feng Ding; Changzhi He; Lei Sun; YanFang Jiang; Liying Zhu
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.752

6.  MicroRNA-410 suppresses migration and invasion by targeting MDM2 in gastric cancer.

Authors:  Jianjun Shen; Weina Niu; Ming Zhou; Hongbo Zhang; Jun Ma; Ling Wang; Hongyan Zhang
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

7.  MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM.

Authors:  Yang Chong; Jie Zhang; Xinzhen Guo; Guojun Li; Shiqian Zhang; Chao Li; Zhijian Jiao; Ming Shao
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

8.  MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma.

Authors:  Lei Shen; Peng Wang; Jili Yang; Xiaotao Li
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

9.  MicroRNA-145 suppresses epithelial to mesenchymal transition in pancreatic cancer cells by inhibiting TGF-β signaling pathway.

Authors:  Shaojun Chen; Junyi Xu; Yao Su; Li Hua; Chengjun Feng; Zhan Lin; Haixin Huang; Yongqiang Li
Journal:  J Cancer       Date:  2020-02-19       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.